CN110184301A - 通过Tild-CRISPR实现高效精确的靶向整合 - Google Patents
通过Tild-CRISPR实现高效精确的靶向整合 Download PDFInfo
- Publication number
- CN110184301A CN110184301A CN201810399266.6A CN201810399266A CN110184301A CN 110184301 A CN110184301 A CN 110184301A CN 201810399266 A CN201810399266 A CN 201810399266A CN 110184301 A CN110184301 A CN 110184301A
- Authority
- CN
- China
- Prior art keywords
- artificial sequence
- dna
- tild
- gene
- crispr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000010354 integration Effects 0.000 title claims abstract description 48
- 238000010354 CRISPR gene editing Methods 0.000 title abstract description 79
- 108020004414 DNA Proteins 0.000 claims abstract description 173
- 108091033409 CRISPR Proteins 0.000 claims abstract description 43
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 39
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 239000013604 expression vector Substances 0.000 claims abstract description 11
- 108091027544 Subgenomic mRNA Proteins 0.000 claims abstract description 9
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 8
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 8
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 48
- 235000013601 eggs Nutrition 0.000 claims description 18
- 239000007924 injection Substances 0.000 claims description 18
- 238000002347 injection Methods 0.000 claims description 18
- 230000029087 digestion Effects 0.000 claims description 11
- 238000000338 in vitro Methods 0.000 claims description 11
- 238000003776 cleavage reaction Methods 0.000 claims description 8
- 230000007017 scission Effects 0.000 claims description 8
- 230000008676 import Effects 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 230000003834 intracellular effect Effects 0.000 claims 1
- 238000010362 genome editing Methods 0.000 abstract description 10
- 239000012634 fragment Substances 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 description 48
- 210000001161 mammalian embryo Anatomy 0.000 description 38
- 241000699666 Mus <mouse, genus> Species 0.000 description 35
- 230000001404 mediated effect Effects 0.000 description 28
- 230000006801 homologous recombination Effects 0.000 description 20
- 238000002744 homologous recombination Methods 0.000 description 20
- 230000008685 targeting Effects 0.000 description 18
- 102000053602 DNA Human genes 0.000 description 16
- 238000003198 gene knock in Methods 0.000 description 16
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 15
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 15
- 210000002257 embryonic structure Anatomy 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 14
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 12
- 108020004682 Single-Stranded DNA Proteins 0.000 description 11
- 101150087690 ACTB gene Proteins 0.000 description 10
- 238000012408 PCR amplification Methods 0.000 description 10
- 210000001109 blastomere Anatomy 0.000 description 10
- 230000005611 electricity Effects 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 101000819088 Homo sapiens Transcription factor GATA-6 Proteins 0.000 description 9
- 102100021382 Transcription factor GATA-6 Human genes 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 8
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 7
- 229960001948 caffeine Drugs 0.000 description 7
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000009261 transgenic effect Effects 0.000 description 7
- 108700028369 Alleles Proteins 0.000 description 6
- 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 6
- 102000006277 CDX2 Transcription Factor Human genes 0.000 description 5
- 108010083123 CDX2 Transcription Factor Proteins 0.000 description 5
- 102000002322 Egg Proteins Human genes 0.000 description 5
- 108010000912 Egg Proteins Proteins 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 210000004681 ovum Anatomy 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 101150003511 NR3C2 gene Proteins 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
- NEEVCWPRIZJJRJ-LWRDCAMISA-N 5-(benzylideneamino)-6-[(e)-benzylideneamino]-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound C=1C=CC=CC=1C=NC=1C(=O)NC(=S)NC=1\N=C\C1=CC=CC=C1 NEEVCWPRIZJJRJ-LWRDCAMISA-N 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 241001529936 Murinae Species 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000004720 fertilization Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000012744 immunostaining Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 108020005004 Guide RNA Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 101150085710 OCT4 gene Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 2
- 208000033040 Somatoform disorder pregnancy Diseases 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 108091028113 Trans-activating crRNA Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 101150063416 add gene Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000002459 blastocyst Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 108091079001 CRISPR RNA Proteins 0.000 description 1
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N CT 99021 Chemical compound CC1=CNC(C=2C(=NC(NCCNC=3N=CC(=CC=3)C#N)=NC=2)C=2C(=CC(Cl)=CC=2)Cl)=N1 AQGNHMOJWBZFQQ-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241001197446 Mus cypriacus Species 0.000 description 1
- 101000942966 Mus musculus Leukemia inhibitory factor Proteins 0.000 description 1
- -1 Nanog Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101000693614 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Nucleoporin alm1 Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 101150038500 cas9 gene Proteins 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- JVHIPYJQMFNCEK-UHFFFAOYSA-N cytochalasin Natural products N1C(=O)C2(C(C=CC(C)CC(C)CC=C3)OC(C)=O)C3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 JVHIPYJQMFNCEK-UHFFFAOYSA-N 0.000 description 1
- 101150109673 dbh gene Proteins 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 210000001733 follicular fluid Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012301 transgenic model Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/10—Vectors comprising a non-peptidic targeting moiety
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810399266.6A CN110184301B (zh) | 2018-04-28 | 2018-04-28 | 通过Tild-CRISPR实现高效精确的靶向整合 |
PCT/CN2019/084372 WO2019206236A1 (zh) | 2018-04-28 | 2019-04-25 | 通过Tild-CRISPR实现高效精确的靶向整合 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810399266.6A CN110184301B (zh) | 2018-04-28 | 2018-04-28 | 通过Tild-CRISPR实现高效精确的靶向整合 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110184301A true CN110184301A (zh) | 2019-08-30 |
CN110184301B CN110184301B (zh) | 2023-02-24 |
Family
ID=67713871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810399266.6A Active CN110184301B (zh) | 2018-04-28 | 2018-04-28 | 通过Tild-CRISPR实现高效精确的靶向整合 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110184301B (zh) |
WO (1) | WO2019206236A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110272900A (zh) * | 2019-04-19 | 2019-09-24 | 中国人民解放军陆军军医大学 | 用于制备骨骼发育异常猪模型的sgRNA及其应用 |
CN111849986A (zh) * | 2020-07-24 | 2020-10-30 | 江苏集萃药康生物科技有限公司 | 一种减少CRISPR-Cas9基因编辑中双链DNA片段串联的方法及其应用 |
CN113249407A (zh) * | 2021-06-02 | 2021-08-13 | 上海南方模式生物科技股份有限公司 | 一种用于同源重组的载体及其应用 |
CN114480386A (zh) * | 2021-04-07 | 2022-05-13 | 成都中科奥格生物科技有限公司 | 转人cd55基因大动物的构建方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105985982A (zh) * | 2015-02-12 | 2016-10-05 | 中国科学院上海生命科学研究院 | 改造斑马鱼基因组的构建物及改造方法 |
CN108866100A (zh) * | 2017-05-16 | 2018-11-23 | 中国科学院上海生命科学研究院 | 一种高效率的基因编辑方法 |
CN109321584A (zh) * | 2017-12-27 | 2019-02-12 | 华东师范大学 | 一种简单定性/定量检测单碱基基因编辑技术工作效率的报告系统 |
CN110396523A (zh) * | 2018-04-23 | 2019-11-01 | 中国科学院上海生命科学研究院 | 一种重复片段介导的植物定点重组方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8697359B1 (en) * | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
CN106191116B (zh) * | 2016-08-22 | 2019-10-08 | 西北农林科技大学 | 基于CRISPR/Cas9的外源基因敲入整合系统及其建立方法和应用 |
-
2018
- 2018-04-28 CN CN201810399266.6A patent/CN110184301B/zh active Active
-
2019
- 2019-04-25 WO PCT/CN2019/084372 patent/WO2019206236A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105985982A (zh) * | 2015-02-12 | 2016-10-05 | 中国科学院上海生命科学研究院 | 改造斑马鱼基因组的构建物及改造方法 |
CN108866100A (zh) * | 2017-05-16 | 2018-11-23 | 中国科学院上海生命科学研究院 | 一种高效率的基因编辑方法 |
CN109321584A (zh) * | 2017-12-27 | 2019-02-12 | 华东师范大学 | 一种简单定性/定量检测单碱基基因编辑技术工作效率的报告系统 |
CN110396523A (zh) * | 2018-04-23 | 2019-11-01 | 中国科学院上海生命科学研究院 | 一种重复片段介导的植物定点重组方法 |
Non-Patent Citations (1)
Title |
---|
XUAN YAO 等: "Homology-mediated end joining-based targeted integration using CRISPR/Cas9", 《CELL RES.》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110272900A (zh) * | 2019-04-19 | 2019-09-24 | 中国人民解放军陆军军医大学 | 用于制备骨骼发育异常猪模型的sgRNA及其应用 |
CN110272900B (zh) * | 2019-04-19 | 2024-03-26 | 中国人民解放军陆军军医大学 | 用于制备骨骼发育异常猪模型的sgRNA及其应用 |
CN111849986A (zh) * | 2020-07-24 | 2020-10-30 | 江苏集萃药康生物科技有限公司 | 一种减少CRISPR-Cas9基因编辑中双链DNA片段串联的方法及其应用 |
CN114480386A (zh) * | 2021-04-07 | 2022-05-13 | 成都中科奥格生物科技有限公司 | 转人cd55基因大动物的构建方法 |
CN113249407A (zh) * | 2021-06-02 | 2021-08-13 | 上海南方模式生物科技股份有限公司 | 一种用于同源重组的载体及其应用 |
CN113249407B (zh) * | 2021-06-02 | 2021-10-26 | 上海南方模式生物科技股份有限公司 | 一种用于同源重组的载体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2019206236A1 (zh) | 2019-10-31 |
CN110184301B (zh) | 2023-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yao et al. | Tild-CRISPR allows for efficient and precise gene knockin in mouse and human cells | |
US20170152526A1 (en) | Engineering of humanized car t-cell and platelets by genetic complementation | |
CN110184301A (zh) | 通过Tild-CRISPR实现高效精确的靶向整合 | |
CN107090470A (zh) | 经遗传修饰的动物及其生成方法 | |
CN107119076A (zh) | 一种免疫缺陷小鼠模型、其制备方法及应用 | |
AU2016344152A1 (en) | Compositions and methods for chimeric embryo-assisted organ production | |
US20190223417A1 (en) | Genetically modified animals having increased heat tolerance | |
CN109837307B (zh) | 建立含外源染色体的胚胎干细胞的方法 | |
CN105899667A (zh) | 用于产生遗传修饰的动物的组合物和方法 | |
JP2019507610A (ja) | CRISPR−Casゲノム編集に基づく、Fel d1ノックアウト並びに関連組成物及び方法 | |
US20210037797A1 (en) | Inducible disease models methods of making them and use in tissue complementation | |
KR20020057943A (ko) | 트랩 벡터 및 이를 이용한 유전자 트랩법 | |
US20200149063A1 (en) | Methods for gender determination and selection of avian embryos in unhatched eggs | |
CN108866100A (zh) | 一种高效率的基因编辑方法 | |
AU2016344144A1 (en) | Engineering of humanized kidney by genetic complementation | |
CN107988257B (zh) | 基于供体细胞dna甲基化水平的修饰提高山羊克隆效率的载体、细胞及方法 | |
US20130053628A1 (en) | Method for cultivating a transgenic animal with increased expression amount of porcine growth hormone | |
CN106978416A (zh) | 一种基因定位整合表达系统及其应用 | |
EP4144857A1 (en) | Animal preparation method | |
CN104388560B (zh) | 一种y染色体标记方法及其应用 | |
Tesson et al. | Genome editing in rats using TALE nucleases | |
CN105132426A (zh) | 一种以RNA介导的特异性敲除FGF5基因获得基因编辑绵羊的方法及其专用sgRNA | |
WO2015162170A1 (en) | Improved method for reconstructing a non-human animal embryo | |
WO2015163711A1 (ko) | 마이오스타틴 유전자를 표적으로 하는 talen 및 이를 이용한 마이오스타틴 유전자가 녹아웃된 동물을 제조하는 방법 | |
WO2019040744A1 (en) | METHODS AND COMPOSITIONS FOR IN SITU GERMINAL GENOMIC GENE ENGINEERING |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200521 Address after: 200031 No. 320, Yueyang Road, Shanghai, Xuhui District Applicant after: Center for excellence and innovation of brain science and intelligent technology, Chinese Academy of Sciences Address before: 200031 Yueyang Road, Shanghai, No. 319, No. Applicant before: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210618 Address after: Room 1002, unit 1, building 7, 160 basheng Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai, 201203 Applicant after: Huida (Shanghai) Biotechnology Co.,Ltd. Address before: 200031 No. 320, Yueyang Road, Shanghai, Xuhui District Applicant before: Center for excellence and innovation of brain science and intelligent technology, Chinese Academy of Sciences |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240103 Address after: 200131 2 / F, unit 3, building 5, 160 basheng Road, Pudong New Area, Shanghai Patentee after: Huida (Shanghai) Biotechnology Co.,Ltd. Patentee after: Huida Gene Therapy (Singapore) Private Ltd. Address before: Room 1002, unit 1, building 7, 160 basheng Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai, 201203 Patentee before: Huida (Shanghai) Biotechnology Co.,Ltd. |